Carlsquare: Mrkt BUZZ Elicera Therapeutics: Grönt ljus från säkerhetskommittén efter fas I

ELICPress release2026-09-09 11:35

Carlsquare Equity Research har publicerat en kommentar efter att DSMB har slutfört sin granskning av fas I-delen av CARMA-studien.

Läs hela kommentaren här.

Om Carlsquare

Carlsquare is a global research firm and financial advisor focusing on M&A, Equity
Research and Growth Equity. Carlsquare has 170 employees with deep sector knowledge in all 11
GICS sectors. The senior equity research team has extensive experience in the stock
environment and several business sectors. The team produces company research reports,
independent valuations and trading notes. The group have offices in Canada, Denmark, France, Germany, Poland, Sweden, United Kingdom and United States. Read more